EUVIMED · CrossrefZeitschrift
Cancer Chemotherapy and Pharmacology
ISSN 0344-5704 · Springer Science and Business Media LLC
Neueste Artikel
Dose finding, bioavailability, and PK-PD of oral triapine with concurrent chemoradiation for locally advanced cervical cancer and vaginal cancer (ETCTN 9892)
HER-2 SMASH
Pharmacokinetic analysis of crushed venetoclax tablets combined with azacitizine for recurrent pediatric acute myeloid leukemia (AML)
WT161, a selective HDAC6 inhibitor, decreases growth, enhances chemosensitivity, promotes apoptosis, and suppresses motility of melanoma cells
Variations in serum concentrations of sunitinib and its metabolites in patients receiving long-term sunitinib treatment
New approach to busulfan dosing in infants and children based on a population pharmacokinetic analysis
A phase 1 study of the combination of BH3-mimetic, navitoclax, and mTORC1/2 inhibitor, vistusertib, in patients with advanced solid tumors
Evolution of computational techniques against various KRAS mutants in search for therapeutic drugs: a review article
Influence of interleukin-6 on the pharmacokinetics and pharmacodynamics of osimertinib in patients with non-small cell lung cancer
Neurofilament light chain as a marker for neuronal damage: integrating in vitro studies and clinical findings in patients with oxaliplatin-induced neuropathy
Potential role of endothelial dysfunction in hypertension and proteinuria in patients with hepatocellular carcinoma receiving atezolizumab plus bevacizumab: a pilot prospective observational study
Clinical relevance of Nectin-4 downregulation and biological changes caused by cytotoxic chemotherapy in bladder cancer
NSABP FC-11: A phase II study of neratinib plus trastuzumab or neratinib plus cetuximab in patients with “quadruple wild-type” (KRAS/NRAS/BRAF/PIK3CA) metastatic colorectal cancer based on HER2 status: amplified, non-amplified (wild-type), or mutated
Anlotinib in cancer therapy: mechanisms of action, clinical applications, and future perspectives
Non-oncologic to oncologic drug: A systematic review of drug repurposing in cancer
Sacituzumab Govitecan initial dose reduction in polish patients with metastatic triple-negative breast cancer: impact on efficacy and safety
Dosing chemotherapy in children with obesity: literature review and evaluation of local practices
An intracerebral microdialysis study to determine the neuropharmacokinetics of eribulin in patients with metastatic or primary brain tumors
Combination of S-1 and the oral ATR inhibitor ceralasertib is effective against pancreatic cancer cells
Pharmacokinetics and clinical outcomes of low-dose nivolumab relative to conventional dose in patients with advanced cancer
Pharmacokinetics of trastuzumab and its efficacy and safety in HER2-positive cancer patients
Development of a novel nomogram for predicting delayed methotrexate excretion following high-dose methotrexate in adult patients with hematologic malignancies
Berberine chloride suppresses pancreatic adenocarcinoma proliferation and growth by targeting inflammation-related genes: an in silico analysis with in vitro and vivo validation
Physiologically-based pharmacokinetic models versus allometric scaling for prediction of tyrosine-kinase inhibitor exposure from adults to children
Aclarubicin: contemporary insights into its mechanism of action, toxicity, pharmacokinetics, and clinical standing
Expression of molecular markers and synergistic anticancer effects of chemotherapy with antimicrobial peptides on glioblastoma cells
Inhibition of proteinase-activated receptor 2 (PAR2) decreased the malignant progression of lung cancer cells and increased the sensitivity to chemotherapy
Prognostic value of RRM1 and its effect on chemoresistance in pancreatic cancer
A phase I study of the ceramide nanoliposome in patients with advanced solid tumors
Mechanism of cisplatin resistance in gastric cancer and associated microRNAs
Jahrgänge
2025 · 1252024 · 1352023 · 982022 · 1332021 · 1812020 · 2012019 · 2612018 · 2362017 · 2682016 · 2822015 · 2872014 · 2882013 · 3312012 · 2872011 · 3602010 · 2512009 · 2982008 · 2382007 · 1972006 · 2702005 · 1772004 · 1802003 · 1602002 · 1502001 · 1882000 · 1691999 · 1851998 · 1331997 · 1871996 · 2091995 · 3401994 · 4061993 · 1781992 · 2591991 · 1781990 · 2371989 · 2791988 · 1441987 · 1771986 · 213
EUVIMED